Jae-Geun Lee, Soohyun Lee, Juhee Jeon, Hyun Gi Kong, Hyun-Ju Cho, Jong-Hwan Kim, Seon-Young Kim, Myung Jin Oh, Daum Lee, Nari Seo, Ki Hun Park, Kweon Yu, Hyun Joo An, Choong-Min Ryu, Jeong-Soo Lee
언어
영어(ENG)
URL
https://www.earticle.net/Article/A415456
※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.
원문정보
초록
영어
Host tp53 mutations are frequently found during the early stages of colitis-associated colorectal cancer (CAC), but whether such mutations induce gut microbiota dysbiosis and chronic intestinal inflammation that contributes to the development of CAC, remains unknown. We found that zebrafish tp53 mutant larvae exhibited elevated intestinal inflammation, by monitoring the NFκB activity in the mid-distal intestines of zebrafish larvae using an NFκB:EGFP transgenic reporter line in vivo as well as neutrophil infiltration into the intestine. This inflammation was due to dysbiotic gut microbiota with reduced diversity, revealed using both 16S rRNA amplicon sequencing and a germfree larva model. In this dysbiosis, Aeromonas spp. were aberrantly enriched as major pathobionts and exhibited the capacity for aggressive colonization in tp53 mutants. Importantly, the ex-germfree experiments supported the causality of the host tp53 mutation for inducing the inflammation. Transcriptome and high performance liquid chromatography analyses of the host gastrointestinal tracts identified dysregulated sialic acid (SA) metabolism concomitant with increased host Neu5Gc levels as the key determinant of aberrant inflammation, which was reversed by the sialidase inhibitors oseltamivir and Philippin A. These results demonstrate a crucial role for host tp53 in maintaining symbiosis and immune homeostasis via SA metabolism. Disturbed SA metabolism via a tp53 mutation may be exploited by specific elements of the gut microbiome, eliciting both dysbiosis and inflammation. Manipulating sialometabolism may therefore provide an efficacious therapeutic strategy for tp53 mutation-induced dysbiosis, inflammation, and, ultimately, related cancers.
저자
Jae-Geun Lee [ Disease Target Structure Research Center, Infectious Disease Research Center, 4KRIBB school, University of Science and Technology, Daejeon ]
Soohyun Lee [ Infectious Disease Research Center ]
Juhee Jeon [ Disease Target Structure Research Center, Stembio. Ltd, Entrepreneur 306, Asan-si, Chungcheongnam-do ]
Hyun Gi Kong [ Infectious Disease Research Center, Crop Protection Division, National Institute of Agricultural Sciences, Rural Development Administration, Wanju-gun, Jeollabuk-do ]
Hyun-Ju Cho [ Disease Target Structure Research Center ]
Jong-Hwan Kim [ Genome Editing Research Center, KRIBB ]
Seon-Young Kim [ Genome Editing Research Center, KRIBB, KRIBB school, University of Science and Technology, Daejeon ]
Myung Jin Oh [ Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon ]
Daum Lee [ Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon ]
Nari Seo [ Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon ]
Ki Hun Park [ Division of Applied Life Science (BK21 plus), IALS, Gyeongsang National University, Jinju-si, Gyeongsangnam-do ]
Kweon Yu [ Disease Target Structure Research Center, Infectious Disease Research Center, 4KRIBB school, University of Science and Technology, Daejeon ]
Hyun Joo An [ Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon ]
Choong-Min Ryu [ Infectious Disease Research Center, KRIBB school, University of Science and Technology, Daejeon ]
Corresponding Author
Jeong-Soo Lee [ Disease Target Structure Research Center, Infectious Disease Research Center, 4KRIBB school, University of Science and Technology, Daejeon ]
Corresponding Author
본 학회는 화학, 생화학, 분자생물학, 미생물학, 식품공학, 의학, 약학, 유전공학 및 생물공학, 환경 및 기타 공업 등 전 분야의 탄수화물관련 이론과 기술을 연구 발전시키고 산학협동을 통해 이를 보급하여 국내 관련 산업의 발전 및 국민생활의 과학화에 기여하고자 하며, 이러한 목표와 비젼의 실현을 위해 회원들이 적극적인 참여와 활동을 전개하고자 한다.